Version 1
: Received: 11 September 2024 / Approved: 16 September 2024 / Online: 16 September 2024 (10:05:00 CEST)
How to cite:
Saeed, M. A.; Marzook, F.; Saeed, M. R.; Majeed, H.; Usman, M.; Arif Sultan, B. Unveiling the Emergency Use Authorization of COVID‐19 Vaccines: Safety, Efficacy and Public Trust. Preprints2024, 2024091204. https://doi.org/10.20944/preprints202409.1204.v1
Saeed, M. A.; Marzook, F.; Saeed, M. R.; Majeed, H.; Usman, M.; Arif Sultan, B. Unveiling the Emergency Use Authorization of COVID‐19 Vaccines: Safety, Efficacy and Public Trust. Preprints 2024, 2024091204. https://doi.org/10.20944/preprints202409.1204.v1
Saeed, M. A.; Marzook, F.; Saeed, M. R.; Majeed, H.; Usman, M.; Arif Sultan, B. Unveiling the Emergency Use Authorization of COVID‐19 Vaccines: Safety, Efficacy and Public Trust. Preprints2024, 2024091204. https://doi.org/10.20944/preprints202409.1204.v1
APA Style
Saeed, M. A., Marzook, F., Saeed, M. R., Majeed, H., Usman, M., & Arif Sultan, B. (2024). Unveiling the Emergency Use Authorization of COVID‐19 Vaccines: Safety, Efficacy and Public Trust. Preprints. https://doi.org/10.20944/preprints202409.1204.v1
Chicago/Turabian Style
Saeed, M. A., Mohammad Usman and Binish Arif Sultan. 2024 "Unveiling the Emergency Use Authorization of COVID‐19 Vaccines: Safety, Efficacy and Public Trust" Preprints. https://doi.org/10.20944/preprints202409.1204.v1
Abstract
The SARS-CoV-2 virus (COVID-19) has led to an initiative to develop safe and effective vaccines for public health safety. In December 2020, the United States Food and Drug Administration (FDA) administered an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. Other vaccines from Johnson & Johnson, Moderna, and AstraZeneca shortly followed. This paper aims to examine the EUA process for COVID-19 vaccine approvals, including the requirements for the safety and efficacy of data, along with the role of the FDA and EMA in the approval process. Further, public concerns about vaccine approvals, including issues on the approval process's safety, efficacy, and speed, were also discussed. Using qualitative analysis of the extracted studies, trends and insights into the factors influencing public acceptance of COVID-19 vaccines, such as vaccine hesitancy and misinformation, were discussed. Overall, a transparent and rigorous regulatory process for vaccine approval is critical for education efforts between policymakers, vaccine developers, and the public to address concerns for increased population vaccine uptake.
Keywords
COVID; United States; Europe; Vaccine Emergency Use Designation; EUA; Vaccine
Subject
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
